{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:02:11Z","timestamp":1794085331135,"version":"4.8.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamaoncol.2019.5868","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T11:33:32Z","timestamp":1579174412000},"page":"358","source":"Crossref","is-referenced-by-count":224,"title":["Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia"],"prefix":"10.1001","volume":"6","author":[{"given":"Shuhong","family":"Shen","sequence":"first","affiliation":[{"name":"National Children\u2019s Medical Center, Department of Hematology\/Oncology, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, Shanghai Children\u2019s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology and Division of Pediatric Blood Diseases Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyang","family":"Cai","sequence":"additional","affiliation":[{"name":"National Children\u2019s Medical Center, Department of Hematology\/Oncology, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, Shanghai Children\u2019s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Chongqing Medical University Affiliated Children\u2019s Hospital, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Children's Hospital of Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Children\u2019s Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changda","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Jiangxi Provincial Children\u2019s Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runming","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Anhui Medical University Second Affiliated Hospital, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Kunming Children\u2019s Hospital, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Xi\u2019an Northwest Women and Children Hospital, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Shanghai Children\u2019s Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Children\u2019s Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-kong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hong Kong Children\u2019s Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Xiangya Hospital Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Disease of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqing","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Jeha","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun J","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Tang","sequence":"additional","affiliation":[{"name":"National Children\u2019s Medical Center, Department of Hematology\/Oncology, Key Laboratory of Pediatric Hematology and Oncology of China Ministry of Health, Shanghai Children\u2019s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology and Division of Pediatric Blood Diseases Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"coi190104r1","first-page":"957","article-title":"Incidence and clinical outcome of children with BCR\/ABL-positive acute lymphoblastic leukemia (ALL): a prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.","volume":"10","author":"Schlieben","year":"1996","journal-title":"Leukemia"},{"issue":"2","key":"coi190104r2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia.","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"coi190104r3","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia.","volume":"342","author":"Aric\u00f2","year":"2000","journal-title":"N Engl J Med"},{"issue":"31","key":"coi190104r4","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","article-title":"Clinical outcome of children with newly diagnosed Philadelphia chromosome\u2013positive acute lymphoblastic leukemia treated between 1995 and 2005.","volume":"28","author":"Aric\u00f2","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"coi190104r5","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3109\/10428194.2016.1157872","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia in China: a retrospective study from the Chinese Childhood Cancer Group.","volume":"57","author":"Gao","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"31","key":"coi190104r6","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: a Children\u2019s Oncology Group study.","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi190104r7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: Children\u2019s Oncology Group study AALL0031.","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"coi190104r8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S1470-2045(12)70377-7","article-title":"Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome\u2013positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.","volume":"13","author":"Biondi","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"coi190104r9","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1016\/S2352-3026(18)30173-X","article-title":"Imatinib treatment of paediatric Philadelphia chromosome\u2013positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.","volume":"5","author":"Biondi","year":"2018","journal-title":"Lancet Haematol"},{"issue":"5","key":"coi190104r10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/cam4.383","article-title":"Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: results from Japanese Pediatric Leukemia\/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04.","volume":"4","author":"Manabe","year":"2015","journal-title":"Cancer Med"},{"issue":"6","key":"coi190104r11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome\u2013positive adult acute lymphoblastic leukemia.","volume":"110","author":"Piccaluga","year":"2007","journal-title":"Cancer"},{"issue":"7","key":"coi190104r12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.clml.2018.05.015","article-title":"SOHO state of the art update and next questions: Philadelphia chromosome\u2013positive acute lymphoblastic leukemia.","volume":"18","author":"Short","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"11","key":"coi190104r13","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","article-title":"In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants.","volume":"65","author":"O\u2019Hare","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"coi190104r14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1182\/blood-2008-02-140665","article-title":"Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome\u2013positive leukemia.","volume":"112","author":"Porkka","year":"2008","journal-title":"Blood"},{"issue":"23","key":"coi190104r15","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1002\/cncr.29646","article-title":"Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia.","volume":"121","author":"Ravandi","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"coi190104r16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1182\/bloodadvances.2016001495","article-title":"US Intergroup Study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL.","volume":"1","author":"Ravandi","year":"2016","journal-title":"Blood Adv"},{"issue":"22","key":"coi190104r17","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1200\/JCO.2017.76.7228","article-title":"Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: results of Children\u2019s Oncology Group Trial AALL0622.","volume":"36","author":"Slayton","year":"2018","journal-title":"J Clin Oncol"},{"key":"coi190104r18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1182\/blood-2017-05-781237","article-title":"CA180-372: an international collaborative phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL).","volume":"130","author":"Hunger","year":"2017","journal-title":"Blood"},{"issue":"26","key":"coi190104r19","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation.","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"key":"coi190104r20","first-page":"S61","article-title":"Treatment of childhood acute lymphoblastic leukemia without cranial irradiation.","volume":"90","author":"Pui","year":"2011","journal-title":"Ann Hematol"},{"issue":"4","key":"coi190104r21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/pbc.v53:4","article-title":"Cost of childhood acute lymphoblastic leukemia care in Shanghai, China.","volume":"53","author":"Liu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"7-8","key":"coi190104r22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0021-9681(74)90015-0","article-title":"The randomization and stratification of patients to clinical trials.","volume":"27","author":"Zelen","year":"1974","journal-title":"J Chronic Dis"},{"issue":"7","key":"coi190104r23","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1182\/blood-2007-02-073528","article-title":"Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study.","volume":"110","author":"Ottmann","year":"2007","journal-title":"Blood"},{"issue":"25","key":"coi190104r24","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1182\/blood-2008-11-186817","article-title":"Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.","volume":"113","author":"Kantarjian","year":"2009","journal-title":"Blood"},{"issue":"10","key":"coi190104r25","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/cncr.28598","article-title":"Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome\u2013positive acute lymphoblastic leukemia.","volume":"120","author":"Jeha","year":"2014","journal-title":"Cancer"},{"issue":"12","key":"coi190104r26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051771","article-title":"SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"coi190104r28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"coi190104r29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"12","key":"coi190104r30","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/leu.2014.142","article-title":"A revised definition for cure of childhood acute lymphoblastic leukemia.","volume":"28","author":"Pui","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"coi190104r31","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"},{"issue":"11","key":"coi190104r32","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/cid\/cix644","article-title":"Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia.","volume":"65","author":"Wolf","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"coi190104r33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ijlh.2018.40.issue-4","article-title":"Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome\u2013positive acute lymphoblastic leukemia using a customized target enrichment system panel.","volume":"40","author":"Aoe","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"coi190104r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.11000","article-title":"International collaboration to save children with acute lymphoblastic leukemia.","volume":"5","author":"Pui","year":"2019","journal-title":"J Glob Oncol"},{"issue":"6","key":"coi190104r35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/archdischild-2018-316181","article-title":"Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children\u2019s Cancer Group.","volume":"104","author":"Cai","year":"2019","journal-title":"Arch Dis Child"},{"key":"coi190104r27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781118032985","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleisch","year":"2002"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2758575\/jamaoncology_shen_2020_oi_190104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T11:01:15Z","timestamp":1584010875000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2758575"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.5868","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}